We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Alico
ALCO
$286M
| – | – |
-22,369
| Closed | -$766K |
|
3652
Alkermes
ALKS
$8.79B
| – | – |
-21,043
| Closed | -$649K |
|
3653
Alnylam Pharmaceuticals
ALNY
$37.2B
| – | – |
-16,427
| Closed | -$3.1M |
|
3654
Allison Transmission
ALSN
$10.1B
| – | – |
-43,689
| Closed | -$1.54M |
|
3655
Altimmune
ALT
$576M
| – | – |
-478,923
| Closed | -$5.42M |
|
3656
AMC Entertainment Holdings
AMC
$2.24B
| – | – |
-1,089
| Closed | -$414K |
|
|
AMED
3657
DELISTED
Amedisys
AMED
| – | – |
-12,477
| Closed | -$1.86M |
|
3658
Amkor Technology
AMKR
$15B
| – | – |
-10,528
| Closed | -$263K |
|
3659
Amneal Pharmaceuticals
AMRX
$5.78B
| – | – |
-472,137
| Closed | -$2.52M |
|
3660
Aemetis
AMTX
$109M
| – | – |
-68,289
| Closed | -$1.25M |
|
3661
Anika Therapeutics
ANIK
$200M
| – | – |
-9,536
| Closed | -$406K |
|
3662
Aptiv
APTV
$12.2B
| – | – |
-3,693
| Closed | -$550K |
|
3663
Arcturus Therapeutics
ARCT
$164M
| – | – |
-11,062
| Closed | -$528K |
|
3664
Artesian Resources
ARTNA
$355M
| – | – |
-10,096
| Closed | -$385K |
|
3665
Asure Software
ASUR
$222M
| – | – |
-22,534
| Closed | -$203K |
|
3666
Atlanticus Holdings
ATLC
$1.58B
| – | – |
-4,049
| Closed | -$215K |
|
3667
Actinium Pharmaceuticals
ATNM
$26.8M
| – | – |
-22,469
| Closed | -$199K |
|
3668
Atomera
ATOM
$203M
| – | – |
-37,755
| Closed | -$872K |
|
3669
Aurora
AUR
$12.2B
| – | – |
-999,944
| Closed | -$9.93M |
|
3670
AeroVironment
AVAV
$7.81B
| – | – |
-30,793
| Closed | -$2.66M |
|
3671
AvePoint
AVPT
$2.72B
| – | – |
-43,165
| Closed | -$366K |
|
3672
Avnet
AVT
$7.25B
| – | – |
-20,940
| Closed | -$774K |
|
3673
Avantor
AVTR
$8.03B
| – | – |
-30,516
| Closed | -$1.25M |
|
3674
CALL
American Express
AXP
$229B
| – | – |
-1,100
| Closed | -$184K |
|
3675
AXT Inc
AXTI
$3.13B
| – | – |
-16,980
| Closed | -$141K |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.